title: The actual therapy and in-hospital mortality of acute myocardial infarction in Flanders. Mirracle's Investigators.
abstract: We studied influences on treatment and mortality in 787 patients with myocardial infarction in the setting of a prospective registry. Fifty % of patients received thrombolytics, 81% aspirin, and 46% beta-blockers. Decisions to give thrombolytics were influenced by gender and function. During hospital stay angioplasty was performed in 21%, and grafting in 11%. In hospital-mortality (11%) was related to age and function. In multivariate analysis, only age influenced the use of angioplasty and revascularization. In conclusion, in-hospital mortality remains high, while 50% of patients receive thrombolytic therapy. Some therapeutic options are highly influenced by age, gender, and cardiac function.
authors.affiliation: Department of Cardiology, University Hospital of Ghent, Belgium.
authors.forename: L
authors.initials: L
authors.lastname: Jordaens
authors.forename: R
authors.initials: R
authors.lastname: Tavernier
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000627:therapeutic use; D001530:Belgium; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy*; D009204:Myocardial Revascularization; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D012042:Registries; D016019:Survival Analysis
chemical_list: D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin